Processa Pharmaceuticals
PCSA | NASDAQ
$1.72
-$0.14 (-7.53%)
At close: Nov 16, 2026, 4:00 PM ET
$1.72
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:54 PM ET
-7.53%
(1D)No price chart data available for 1D timeframe.
Rating
37
+1.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #616/1021 (Top 60%)
Key Statistics
Market Data
Market Cap $5.12M
1D Range
1.64 1.84
52W Range
1.35 7.65
Valuation (TTM)
PE -0.03
PB 0.03
EV/EBITDA N/A
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $225.00
Cash Flow
FCF Yield -267.1%
SBC Adj. FCF Yield -289.7%
SBC Impact -8.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 32.7% |
54.3%
FCF 3Y | 5Y -10.7% |
-9.3%
Returns
ROA -106.1%
ROE -411.1%
ROIC -8.2%
Financial Health
Net Cash
$180.64M
Current Ratio 97.70
Interest Coverage -7,373.06
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical re...
Sector Healthcare
Industry Biotechnology
Employees 12
IPO Date Mar 7, 2014
Website www.processapharmaceuticals.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove PCSA